Inovio Pharma (INO) Reports Encouraging Data from PENNVAX-B Phase I

Go back to Inovio Pharma (INO) Reports Encouraging Data from PENNVAX-B Phase I
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 1.25 +0.07 (5.93%)
Previous Close $1.18    52 Week High $11.69 
Open $1.19    52 Week Low $4.50 
Day High $1.30    P/E N/A 
Day Low $1.15    EPS $-0.28 
Volume 4,591,758